NCT00679185View on ClinicalTrials.gov

Expressive Writing in Improving Quality of Life in Patients With Breast Cancer and Lymphedema

NACompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Breast CancerFatigueLymphedema
Interventions
BEHAVIORAL

expressive writing

four non-emotional writing assignments

Trial Locations (3)

37064

Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville

Vanderbilt-Ingram Cancer Center at Franklin, Nashville

37232-6838

Vanderbilt-Ingram Cancer Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Vanderbilt University

OTHER

NCT00679185 - Expressive Writing in Improving Quality of Life in Patients With Breast Cancer and Lymphedema | Biotech Hunter | Biotech Hunter